Session ID: 

The Evolving Healthcare Ecosystem: What Do Providers Want From Pharma?

12:50pm - 1:25pm Tuesday, February 12
Orlando - Rosen Centre
Rosen Centre Grand Ballroom C
Extra Fee


The world is changing for Big Pharma. Driven by value-based care, reimbursement will increasingly be tied to drug effectiveness and outcomes. Competition is growing and market share slipping. To offset these challenges, pharma must forge new strategic alliances, drive efficiencies, speed up clinical trials, and develop targeted therapies as healthcare moves to more personalized care and precision medicine. Technology will drive this paradigm shift.

For this session, HIMSS has assembled a panel of industry thought-leaders to discuss the current state of pharma-payer-provider collaborations. Importantly, the panel will address the question that seems top of mind for many in the pharmaceutical industry: What do healthcare providers expect of pharmaceutical companies in the new healthcare ecosystem?

Key Takeaways

• What are the opportunities for all stakeholders, including patients?
• How will health IT will help drive this new business model?
• How can all stakeholders work together to improve patient access, experience and outcomes?

This session is part of a special program called HIMSS19 Pharma Forum. Extra fees and separate registration is required.


Medical Director,
CHOC Children
Founder and CEO,
WEGO Health
International Healthcare Innovation Professor,
Harvard Medical School
Executive Vice President / Chief Strategy Officer,
Atrium Health
Executive Director and Head of Digital Strategy and Medical Innovation,
Novartis Pharmaceuticals


Chief Quality, Chief Clin Transformation Officer
Life Sciences Professionals